{"disease":{"id":"cidp","name":"cidp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05363358","title":"A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06040567","title":"Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study","phase":"","overall_status":"RECRUITING","enrollment_count":520,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04281472","title":"A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":322,"lead_sponsor_name":"argenx","has_results":true},{"nct_id":"NCT04280718","title":"A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":229,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT04249752","title":"Biomarkers in Polyradiculoneuropathies","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05004493","title":"Biorepository and Registry for Plasma Exchange Patients","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Charles M Knudson","has_results":false},{"nct_id":"NCT06858722","title":"Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":175,"lead_sponsor_name":"Zhongming Qiu","has_results":false},{"nct_id":"NCT07091630","title":"A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT02027701","title":"Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT04589299","title":"Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06747351","title":"A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":59,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05723848","title":"Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy","phase":"","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT03460951","title":"Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT02629796","title":"Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT07337785","title":"CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Daishi Tian","has_results":false},{"nct_id":"NCT06798012","title":"A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03861481","title":"A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true},{"nct_id":"NCT03166527","title":"Panzyga in CIDP Administered at Different Infusion Rates","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Vera Bril","has_results":false},{"nct_id":"NCT06538064","title":"A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03684018","title":"Two Dose Levels of Privigen in Pediatric CIDP","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT07121985","title":"Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT05084053","title":"A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03864185","title":"The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Nagoya University","has_results":false},{"nct_id":"NCT04051944","title":"A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT04881682","title":"Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Ulm","has_results":false},{"nct_id":"NCT05584631","title":"IVIG vs SCIG in CIDP","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT03801135","title":"Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT05492604","title":"Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP.","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07343310","title":"A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Kine Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT07526493","title":"Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05614128","title":"Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT05014724","title":"CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"UCB Biopharma SRL","has_results":false},{"nct_id":"NCT04777734","title":"Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"argenx","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}